Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infections.
van Rossum AM, Niesters HG, Geelen SP, Scherpbier HJ, Hartwig NG, Weemaes CM, Veerman AJ, Suur MH, de Graeff-Meeder ER, Slieker WA, Hop WC, Osterhaus AD, Burger DM, De Groot R. van Rossum AM, et al. Among authors: burger dm. J Pediatr. 2000 Jun;136(6):780-8. doi: 10.1067/mpd.2000.106234. J Pediatr. 2000. PMID: 10839877 Clinical Trial.
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children.
Burger DM, van Rossum AM, Hugen PW, Suur MH, Hartwig NG, Geelen SP, Scherpbier HJ, Hoetelmans RM, Vulto AG, de Groot R; Dutch Study Group for Children with HIV-1 Infection. Burger DM, et al. Antimicrob Agents Chemother. 2001 Mar;45(3):701-5. doi: 10.1128/AAC.45.3.701-705.2001. Antimicrob Agents Chemother. 2001. PMID: 11181346 Free PMC article. Clinical Trial.
A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacy.
Burger DM, Hugen PW, Aarnoutse RE, Dieleman JP, Prins JM, van der Poll T, ten Veen JH, Mulder JW, Meenhorst PL, Blok WL, van der Meer JT, Reiss P, Lange JM. Burger DM, et al. J Acquir Immune Defic Syndr. 2001 Mar 1;26(3):218-24. doi: 10.1097/00042560-200103010-00003. J Acquir Immune Defic Syndr. 2001. PMID: 11242194 Free article. Clinical Trial.
Indinavir crystallization around the loop of Henle: experimental evidence.
Dieleman JP, Salahuddin S, Hsu YS, Burger DM, Gyssens IC, Sturkenboom MC, Stricker BH, Kok DJ. Dieleman JP, et al. Among authors: burger dm. J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):9-13. doi: 10.1097/00042560-200109010-00002. J Acquir Immune Defic Syndr. 2001. PMID: 11579271
Results of 2 years of treatment with protease-inhibitor--containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1.
van Rossum AM, Geelen SP, Hartwig NG, Wolfs TF, Weemaes CM, Scherpbier HJ, van Lochem EG, Hop WC, Schutten M, Osterhaus AD, Burger DM, de Groot R. van Rossum AM, et al. Among authors: burger dm. Clin Infect Dis. 2002 Apr 1;34(7):1008-16. doi: 10.1086/339443. Epub 2002 Mar 4. Clin Infect Dis. 2002. PMID: 11880968 Clinical Trial.
496 results